Lerner Medical Devices, Inc.'s Levia Personal Targeted Phototherapy(R) Recently Receives Trademark

LOS ANGELES, CA--(Marketwire - May 05, 2010) -

The United States Patents and Trademark Office (USPTO) recently issued the trademark to Lerner Medical Devices, Inc. for Personal Targeted Phototherapy®. Levia® Personal Targeted Phototherapy with Ultraviolet B (UVB) light is a safe and effective non-drug option for the self-treatment of psoriasis in the privacy and convenience of a patient’s home.

“Personal Targeted Phototherapy is a new class and unique treatment for psoriasis and we are pleased that this distinction has been recognized by the granting of a trademark,” said Zafiris Gourgouliatos, Ph.D., Chief Technology Officer, and Co-Founder.

Levia® Personal Targeted Phototherapy is purpose-designed to provide treatment of scalp and small area psoriasis flare-ups in the home environment, with physician control and oversight. Levia’s proprietary touch-screen user interface permits the patient to manage the delivery of a physician-prescribed treatment regimen with appropriate flexibility. Proprietary beam delivery attachments, Lite-Brush™ and Lite-Spot™, direct the UVB light to the affected areas of scalp and skin. This precise targeting minimizes exposure of uninvolved areas and facilitates controlled and rapid treatment.

Levia was introduced March 2010 at the 68th Annual Meeting of the American Academy of Dermatology, Miami, Florida and at the 28th Annual Convention of the Dermatology Nurses Association in Orlando, Florida.

To learn more about Levia visit www.mylevia.com.

About Lerner Medical Devices, Inc.
Lerner Medical Devices is focused on the use of ultraviolet B phototherapy for self-treatment of psoriasis and other photo-responsive skin conditions. Levia® is the first of their Personal Targeted Phototherapy™ products; it is designed to facilitate safe and effective management of psoriasis in a home environment and incorporates:

• Proprietary beam delivery attachments to direct UVB light precisely to the affected areas of skin and scalp.
• Touch screen interface for maximum control by patients in accordance with preset instructions from the prescribing physician.

To learn more about Levia® and Lerner Medical, please visit www.mylevia.com.
Find Levia on Facebook: http://www.facebook.com/mylevia
Follow Levia on Twitter: http://www.twitter.com/mylevia

Digg this Bookmark with del.icio.us Add to Newsvine

Technorati: Psoriasis Phototherapy Trademark Miami Lerner Medical Levia Personal Targeted Ultraviolet B